KineMed, Inc., a translational and personalized medicine development company, announced a broadening of its collaboration with Bristol-Myers Squibb Compa Read More >>

Research and Markets (http://www.researchandmarkets.com/research/9eb11c/bristolmyers_squi) has announced the addition of the "Bristol-Myers Squibb Read More >>

KineMed, a translational and personalized medicine development company, has broadened its collaboration with Bristol-Myers Squibb Company in the area of Alz Read More >>

KineMed, Inc. a translational and personalized medicine development company, today announced a broadening of its collaboration wi Read More >>

While Pfizer Inc. is thinning its ranks, drugmaker Bristol-Myers Squibb is taking another tack by freezing salaries and Read More >>

It's the ultimate in outsourcing.

A 29-year-old Indian technical operations associate based in Syracuse, N.Y., Read More >>

Research and Markets (http://www.researchandmarkets.com/research/a50e56/partnering_agreeme) has announced the addition of the "Partnering Agr Read More >>

Repligen Corporation (Nasdaq: RGEN) today reported results for the third quarter of fiscal year 2010, ended December 31, 2009. Total revenu Read More >>

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

Bristol-Myers Squibb Company announced it has released fourth quarter sales and earnings results.

In a January 28 release, Bristol-Myers Squibb s Read More >>

Bristol Myers Squibb Co (BMY)

Expected next earnings release:

Announcement date: 4/28/2010 - Before Market

Earnings Quarter: Q1

Ann
          
            Read More
            >>
          
        

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and Read More >>

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

Research and Markets(http://www.researchandmarkets.com/research/81540d/baby_foods_and_inf) has announced the addition of the "Baby Foods and Infant Read More >>

Bristol Myers Squibb Co (BMY)

Expected next earnings release:

Announcement date: 1/28/2010 - Before Market

Earnings Quarter: Q4

Ann
          
            Read More
            >>
          
        

Bristol-Myers Squibb Company has reported that the European Commission approved Orencia in combination with methotrexate for the treatment of moderate to se Read More >>

In a late day advance Wednesday after the Fed reported it would keep interest rates near zero and that the economy was gaining strength, stocks began to rally Read More >>

Bristol-Myers Squibb Company (NYSE: BMY) said it expects 2010 earnings of $2.15 to $2.25 per share. The current consensus earnings e Read More >>

--Continued Focus on Productivity Leads to Improved Operating Margins

--Financial Strength Reflected in Year-End Cash and Marketable Securities of Read More >>

(Comment on this article at http://www.financialwire.net/2010/01/28/conference-calls-today-1030-a-m-est-3/)

January 28, 2010 (FinancialWire) (Inv Read More >>

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, January 28th and determining how the Read More >>

UCB's new rheumatoid arthritis drug, Cimzia, has been recommended for use on the NHS but only in conjunction with a company-sponsored patient access scheme. Read More >>

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

Bristol-Myers Squibb Company (NYSE: BMY) today announced that on 20 January 2010, the European Commission approved ORENCIA(R) (abatacept) in c Read More >>

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinical Practice Guidelines for Oncology(TM) for Ov Read More >>

Bristol Myers Squibb Co (BMY)

Expected next earnings release:

Announcement date: 1/28/2010 - Before Market

Earnings Quarter: Q4

Ann
          
            Read More
            >>
          
        

Bristol Myers Squibb Co (BMY)

Expected next earnings release:

Announcement date: 1/28/2010 - Before Market

Earnings Quarter: Q4

Ann
          
            Read More
            >>
          
        

As the need for health care assistance mounts in Haiti after last week's catastrophic earthquake, America's pharmaceutical research and biotechn Read More >>

SmarTrend identified an Uptrend for Bristol-Myers Squibb (NYSE:BMY) on July 30, 2009 at $21.76. In approximately 6 months, Bristol-Myers Squibb h Read More >>

SmarTrend identified an Uptrend for Bristol-Myers Squibb (NYSE:BMY) on July 30, 2009 at $21.76. In approximately 6 months, Bristol-Myers Squibb h Read More >>

(Comment on this article at http://www.financialwire.net/2010/01/12/conference-calls-today-12-1230-p-m-edt/)

January 12, 2010 (FinancialWire) (In Read More >>

Facet Biotech Corporation (NASDAQ: FACT) today announced enrollment of the first patient into the randomized phase 2 portion of the ongoi Read More >>

Bristol-Myers Squibb Company will announce results for the fourth quarter and full year of 2009 on Thursday, January 28.

In a release, the Compan Read More >>

SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NYSE:BMY) Read More >>

The Association of Clinical Research Organizations (ACRO), which represents the global clinical outsourcing industry to regulators, bioph Read More >>

Bristol Myers Squibb Co (BMY)

Expected next earnings release:

Announcement date: 1/28/2010 - Before Market

Earnings Quarter: Q4

Ann
          
            Read More
            >>
          
        

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

Seven Summits Research issues PriceWatch Alerts for COF, BMY, GRMN, WDC, and IP.

Seven Summits Strategic Investments' PriceWatch Alerts are Read More >>

Bristol-Myers Squibb Company (NYSE: BMY) will present at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010 in Read More >>

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the tre Read More >>

Bristol Myers Squibb Co (BMY)

Expected next earnings release:

Announcement date: 1/28/2010 - Before Market

Earnings Quarter: Q4

Ann
          
            Read More
            >>